Seegene, Inc. (KOSDAQ:096530)

South Korea · Delayed Price · Currency is KRW

36,900

-400 (-1.07%)

Oct 2, 2026, 3:30 PM KST

Market Cap	1.70T +48.9%
Revenue (ttm)	509.27B +12.1%
Net Income	91.74B
EPS	1,998.06
Shares Out	45.56M
PE Ratio	18.67
Forward PE	18.99
Dividend	1,000.00 (2.71%)
Ex-Dividend Date	Jun 29, 2026

Volume	255,353
Open	37,200
Previous Close	37,300
Day's Range	36,350 - 37,650
52-Week Range	21,700 - 37,650
Beta	0.92
Analysts	Buy
Price Target	45,500.00 (+23.31%)
Est. Earnings	Nov 6, 2026

About Seegene

Seegene, Inc. manufactures and sells molecular diagnostics products worldwide. It offers IVD products comprising respiratory disease detection products for respiratory infections; gastrointestinal disease detection products for gastrointestinal tract infections; human papillomavirus detection products; sexually transmitted infections causative pathogens detection products; tuberculosis detection products; drug resistance products; Magicplex sepsis real-time test for the detection and identification of sepsis causing pathogens; and meningitis de... [Read more]

Industry Medical Devices

Sector Healthcare

Founded 2000

Employees 761

Stock Exchange KOSDAQ

Ticker Symbol 096530

Full Company Profile

Financial Performance

Financial Statements

Analyst Summary

According to 2 analysts, the average rating for 096530 stock is "Buy." The 12-month stock price target is ₩45,500, which is an increase of 23.31% from the latest price.

Price Target

₩45,500

(23.31% upside)

Analyst Consensus: Buy

Stock Forecasts